Janelle Muranaka

Janelle is the vice president of operations at Meissa Vaccines. She has more than 11 years of combined experience in cell and molecular biology research, early stage vaccine research and development (R&D), and startup operations, being fully integrated across all functions of the company. Previously, Janelle was the director of operations at Maxygen, a directed evolution service company creating diverse libraries for protein engineering. Prior to the founding of Maxygen LLC, she was director of operations at Altravax, a vaccine startup developing novel vaccine immunogens for chronic hepatitis B, dengue, influenza, and HIV utilizing molecular breeding technology. Janelle also held several research roles at Altravax, Codexis, and Maxygen Inc, and currently serves as a co-organizer for life science events for East Bay Bio Network and NextTech Speaker Series to drive a local ecosystem of entrepreneurship and innovation in the Tri-Valley. ​